In support of direct evidence connecting FGF23-FGFR4 binding to LVH development, Han et al [32] found that cardiomyocyte-specific Fgfr4-knockout mice were resistant to FGF23-induced cardiac hypertrophy by repeated injection of recombinant FGF23. The gene discussed is FGFR4; the disease is cardiac hypertrophy.